{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:57Z","timestamp":1790516157575,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.lpm.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T18:02:21Z","timestamp":1566496941000},"page":"842-849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Leuc\u00e9mie \u00e0 tricholeucocytes"],"prefix":"10.1016","volume":"48","author":[{"given":"Elsa","family":"Maitre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Wiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Cornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2019.07.026_bib0155","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016\u00a0revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2019.07.026_bib0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/CCO.0000000000000214","article-title":"New insights in the management of patients with hairy cell leukemia","volume":"27","author":"Cornet","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jncimonographs\/lgu004","article-title":"Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the interlymph non-hodgkin lymphoma subtypes project","volume":"2014","author":"Monnereau","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.lpm.2019.07.026_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2019.07.026_bib0175","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/bjh.12908","article-title":"Long-term follow-up and second malignancies in 487\u00a0patients with hairy cell leukaemia","volume":"166","author":"Cornet","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1888","article-title":"Evolving concepts in the pathogenesis of hairy-cell leukaemia","volume":"6","author":"Tiacci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lpm.2019.07.026_bib0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors","volume":"199","author":"Basso","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2019.07.026_bib0190","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","article-title":"Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia","volume":"373","author":"Tiacci","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.07.026_bib0195","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lpm.2019.07.026_bib0200","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.12824","article-title":"Usefulness of CD200\u00a0in the differential diagnosis of SDRPL, SMZL, and HCL","author":"Favre","year":"2018","journal-title":"Int J Lab Hematol [Internet]"},{"key":"10.1016\/j.lpm.2019.07.026_bib0205","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1158\/0008-5472.CAN-15-0893","article-title":"CD38\u00a0in hairy cell leukemia is a marker of poor prognosis and a new target for therapy","volume":"75","author":"Poret","year":"2015","journal-title":"Cancer Research"},{"key":"10.1016\/j.lpm.2019.07.026_bib0210","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.07.026_bib0215","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3109\/10428194.2016.1173212","article-title":"Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets","volume":"57","author":"Bogusz","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lpm.2019.07.026_bib0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/bjh.12735","article-title":"Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias","volume":"165","author":"Tschernitz","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0225","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","article-title":"Both variant and IGHV4-34\u2013expressing hairy cell leukemia lack the BRAF V600E mutation","volume":"119","author":"Xi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2019.07.026_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1\u00a0mutations in variant and IGHV4-34\u2013expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2019.07.026_bib0235","doi-asserted-by":"crossref","first-page":"e0149162","DOI":"10.1371\/journal.pone.0149162","article-title":"Exome sequencing in classic hairy cell leukaemia reveals widespread variation in acquired somatic mutations between individual tumours apart from the signature BRAF V(600)E Lesion. Richards KL, editor","volume":"11","author":"Weston-Bell","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lpm.2019.07.026_bib0240","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2015-04-643361","article-title":"Recurrent CDKN1B (p27) mutations in hairy cell leukemia","volume":"126","author":"Dietrich","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2019.07.026_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18632\/oncotarget.25601","article-title":"New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes","volume":"9","author":"Maitre","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lpm.2019.07.026_bib0250","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","article-title":"Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2019.07.026_bib0255","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2016-01-689422","article-title":"Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia","volume":"129","author":"Grever","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2019.07.026_bib0260","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.beha.2015.10.019","article-title":"Bone marrow and splenic histology in hairy cell leukaemia","volume":"28","author":"Wotherspoon","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0265","doi-asserted-by":"crossref","first-page":"238ra71","DOI":"10.1126\/scitranslmed.3008004","article-title":"Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lpm.2019.07.026_bib0270","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2\u00a0mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2019.07.026_bib0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.beha.2015.09.002","article-title":"Hairy cell leukaemia-variant: Disease features and treatment","volume":"28","author":"Matutes","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0280","first-page":"1","article-title":"Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies","author":"Traverse-Glehen","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lpm.2019.07.026_bib0285","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.beha.2015.10.015","article-title":"Hairy cell leukemia: Past, present and future","volume":"28","author":"Getta","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0290","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.14129","article-title":"Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial","volume":"174","author":"Chihara","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2019.07.026_bib0295","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2015-11-680074","article-title":"BRAF inhibition in hairy cell leukemia with low-dose vemurafenib","volume":"127","author":"Dietrich","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.lpm.2019.07.026_bib0150","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/s41375-018-0210-1","article-title":"Moxetumomab pasudotox in relapsed\/refractory hairy cell leukemia","volume":"32","author":"Kreitman","year":"2018","journal-title":"Leukemia"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219303380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219303380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:13Z","timestamp":1760105113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498219303380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":30,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0755498219303380"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2019.07.026","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leuc\u00e9mie \u00e0 tricholeucocytes","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}